The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Thoracent sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Thoracent is a medical equipment company that distributes non-vascular stents. The company offers non-vascular stents, GI devices, and supporting products. Its product portfolio includes tracheobronchial stent, Y-shaped tracheal stent, and esophageal stent. It also provides thoracent pulmonary products like EBUS needles, netis retrieval net, and biopsy forceps. The company provides its products across the US. Thoracent is headquartered in Huntington, New York, the US.
The key metrics of Thoracent related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Thoracent is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Thoracent.
For a detailed understanding of the performance of Thoracent, buy the report here.